Novavax NVAX Provision for excess and obsolete inventory
Provision for excess and obsolete inventory at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept nvax:ProvisionForExcessAndObsoleteInventory.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's provision for excess and obsolete inventory.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's provision for excess and obsolete inventory?
- Novavax (NVAX) reported provision for excess and obsolete inventory of $0 in Q1 2026.
- How has Novavax's provision for excess and obsolete inventory changed year-over-year?
- Novavax's provision for excess and obsolete inventory decreased by 100.0% year-over-year, from $276K to $0.
- What is the long-term trend for Novavax's provision for excess and obsolete inventory?
- Over 3 years (2022 to 2025), Novavax's provision for excess and obsolete inventory has grown at a -83.7% compound annual growth rate (CAGR), from $447.6M to $1.95M.
- What does provision for excess and obsolete inventory mean?
- Reflects the non-cash expense recorded to write down inventory that is no longer expected to be sold or used in production due to expiration, technological obsolescence, or changes in demand. High levels of this provision often signal risks in supply chain management or product lifecycle planning. It serves as a key indicator of inventory quality and potential future margin pressure.